Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW 3,765.00
-105.00 (-2.71%)
At close: Nov 21, 2025
Bukwang Pharmaceutical Market Cap
Bukwang Pharmaceutical has a market cap or net worth of 389.23 billion as of November 26, 2025. Its market cap has increased by 16.40% in one year.
Market Cap
389.23B
Enterprise Value
252.33B
Revenue
184.38B
Ranking
n/a
PE Ratio
30.21
Stock Price
3,765.00
Market Cap Chart
Since August 29, 1995, Bukwang Pharmaceutical's market cap has increased from 63.76B to 389.23B, an increase of 510.50%. That is a compound annual growth rate of 6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 389.23B | 23.88% |
| Dec 30, 2024 | 314.21B | -24.75% |
| Dec 28, 2023 | 417.57B | -30.29% |
| Dec 29, 2022 | 598.98B | -32.17% |
| Dec 30, 2021 | 883.07B | -54.11% |
| Dec 30, 2020 | 1.92T | 109.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.84T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.54T |
| Yuhan | 8.55T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.25T |